145 related articles for article (PubMed ID: 18915)
1. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine.
Simonová I; Závadová H; Vonka V
Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915
[TBL] [Abstract][Full Text] [Related]
2. UV-inactivation of Epstein-Barr virus: differences in early antigen expression in two different non-productive cell lines and influence of caffeine.
Suchánková A; Vonka V
Acta Virol; 1978 Sep; 22(5):383-90. PubMed ID: 30263
[TBL] [Abstract][Full Text] [Related]
3. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
Prachová K; Roubal J
Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
[TBL] [Abstract][Full Text] [Related]
4. Effect of n-butyrate on superinfection of Raji lymphoblastoid cell line by Epstein-Barr virus.
Roubal J; Roubalová K
Acta Virol; 1985 Mar; 29(2):162-5. PubMed ID: 2860802
[TBL] [Abstract][Full Text] [Related]
5. A novel early antigen associated with Epstein-Barr virus productive cycle.
Freemer CS; Bertoni G; Takagi S; Sairenji T
Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
[TBL] [Abstract][Full Text] [Related]
6. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment.
Shapiro IM; Andersson-Anvret M; Klein G
Intervirology; 1978; 10(2):94-101. PubMed ID: 209000
[TBL] [Abstract][Full Text] [Related]
7. Biological characterization of an Epstein-Barr nuclear antigen-positive American Burkitt's tumor-derived cell line.
Hillman EA; Charamella LJ; Temple MJ; Elser JE
Cancer Res; 1977 Dec; 37(12):4546-58. PubMed ID: 200355
[TBL] [Abstract][Full Text] [Related]
8. Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus.
Glaser R; Lenoir G; Ferrone S; Pellegrino MA; de-Thé G
Cancer Res; 1977 Jul; 37(7 Pt 1):2291-6. PubMed ID: 193641
[TBL] [Abstract][Full Text] [Related]
9. Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine.
Souyri-Caporale M; Tovey MG; Ono K; Jasmin C; Chermann JC
J Gen Virol; 1984 Apr; 65 ( Pt 4)():831-5. PubMed ID: 6323625
[TBL] [Abstract][Full Text] [Related]
10. Effect of indomethacin on Epstein-Barr virus early antigen induction.
Daniel LW; Bauer G; zur Hausen H
Cancer Res; 1984 Mar; 44(3):981-3. PubMed ID: 6318991
[TBL] [Abstract][Full Text] [Related]
11. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
12. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids.
Klein G; Clements G; Zeuthen J; Westman A
Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751
[TBL] [Abstract][Full Text] [Related]
14. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
Coker-Vann M; Dolin R
J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of human recombinant interferons on the expression of two early gene products of Epstein-Barr virus.
Lidin B; Lamon EW
Antiviral Res; 1992 Jan; 17(1):79-89. PubMed ID: 1371044
[TBL] [Abstract][Full Text] [Related]
16. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
[TBL] [Abstract][Full Text] [Related]
17. The effects of mitogens on the expression of Epstein-Barr virus antigens in human lymphoid cell lines.
Tovey MG; Lenoir G; Begon-Lours J; Tapiero H; Rochette-Egly C
J Immunol; 1979 Jul; 123(1):138-42. PubMed ID: 221589
[TBL] [Abstract][Full Text] [Related]
18. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
Takimoto T; Sato H; Ogura H; Glaser R
Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
[TBL] [Abstract][Full Text] [Related]
19. Transcription of Epstein-Barr virus genomes in human lymphoblastoid cells and in somatic-cell hybrids of Burkitt's lymphoma.
Nonoyama M; Tanaka A; Silver S; Glaser R
IARC Sci Publ (1971); 1978; (24 Pt 1):559-63. PubMed ID: 221360
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
Yamamoto N; Mueller-Lantzsch N; zur Hausen H
Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
